We focus on optimizing your complete health, longevity, and vitality through evidence-based care
In November 2023, the FDA added BPC-157 to its list of substances that cannot be used in compounding under the Federal Food, Drug, and Cosmetic Act, citing insufficient safety data for human use 3
Looking ahead, the drug pricing will continue to compress with direct-to-consumer programs, innovative pricing models and the approval of oral GLP-1 medications, all likely to influence market dynamics over the next few years
The practical takeaway: if a patient presents with hair thinning, skin aging, and slow wound recovery, GHK-Cu is the right primary peptide
Heres a look at some potential interactions: Combined Therapy Combining GLP-1 agonists with hormonal treatments, such as oral contraceptives or GnRH agonists, may offer several potential benefits for managing endometriosis and related symptoms